Xi 'an Goldmag Nano-Biotechnology Co., LTD. (GOLDMAG) was established in 2010. It is a national high-tech enterprise specializing in the research and development, production and sales of medical devices (in vitro diagnostic reagents and instruments), and a "Specialized, refined, Unique and Innovative" small and medium-sized enterprise in Shaanxi Province. Star of Hard Technology Enterprises in Xi 'an City. The company has been approved to establish a series of new research and development institutions, including the Shaanxi Province "Four Subjects and One Joint" University-Enterprise Joint Research Center for In Vitro Diagnostic Innovation, the Shaanxi Province Engineering Research Center for Nano-Biomedical Detection, the Shaanxi Province Academician and Expert Workstation, the Xi 'an City Engineering Research Center for Clinical In Vitro Diagnostic Reagents, and the Shaanxi Province and Xi 'an City Postdoctoral Innovation Base. It is a hard-tech enterprise with considerable influence in the domestic in vitro diagnostic reagent industry.
The company possesses a core group of invention patents including nanomaterial synthesis and innovative clinical diagnosis technologies, with over 40 authorized invention patents (including 2 US invention patents). Taking the original innovation "GoldMag® Gold Magnetic Particle" as the carrier, we have established for the first time in the world two major platforms: "PCR-Gold Magnetic Particle Chromatography" for gene detection and "Gold Magnetic Particle immunochromatography" for protein bedtime quantitative detection. At the same time, we have also built in vitro diagnostic technology platforms such as fluorescence PCR, immunoturbidimetry, magnetic enzyme immunochemiluminescence, and coagulation detection. The product focuses on the early screening, medication monitoring and prognosis evaluation of major cardiovascular and cerebrovascular diseases in clinical practice. It proactively addresses the aging population and the "three highs" population, actively integrates into the disease and health management industry, and contributes to the "Healthy China" action plan.
GOLDMAG has a 3,000-square-meter R&D and production base for in vitro diagnostic reagents in the High-tech Zone of Xi 'an. It holds the third-class "Medical Device Production License" and has passed the ISO13485 medical device quality management system certification of TUV Rheinland in Germany. The series of diagnostic kits and instrument products have been applied in clinical diagnosis, disease screening and chronic disease management fields such as cardiovascular and cerebrovascular inflammation and personalized medication gene testing. The company has obtained 38 registration certificates for medical devices (in vitro diagnostic reagents) (including 4 Class III ones), and its products have been clinically promoted and applied in over 400 medical institutions across the country.
2010
Years49
38
2
600
The team possesses a core group of invention patents including nanomaterial synthesis, biomolecular markers, and clinical diagnostic methodology research, with 46 authorized invention patents (including 2 US invention patents). We have obtained 38 medical device registration certificates approved by the National Medical Products Administration, and 16 IVD products have been certified by the EU CE. The project related to the oxidized low-density lipoprotein kit developed by the team won numerous awards in 2024, such as: Third Prize in the "Three New and Three Small" Innovation Competition Project of Shaanxi Province Enterprises, Third Prize in the Fifth China Health Industry Innovation Platform Qipu Award, Second Prize in the Shaanxi Province Science and Technology Workers' Innovation and Entrepreneurship Competition of Qinchuangyuan, Third Prize in the Special Competition of the Ninth "Maker China" Biomedical Small and Medium-sized Enterprises Innovation and Entrepreneurship Competition, First Prize in the Seventh China Medical Device Innovation and Entrepreneurship Competition, etc. The team has successively presided over and completed six major new drug creation projects and national high-tech research and development program projects, as well as four national Natural Science Foundation and national major scientific and technological achievement transformation projects, all of which have been successfully concluded. In the past three years, the company has undertaken or participated in 2 national key research and development projects, 2 provincial key research and development projects and technology transfer projects, and 3 municipal science and technology projects. All of them have completed the corresponding performance tasks and been successfully concluded.
The team has successively presided over and completed six major new drug creation projects and national high-tech research and development program projects, as well as four national Natural Science Foundation and national major scientific and technological achievement transformation projects, all of which have been successfully concluded. In the past three years, the company has undertaken or participated in 2 national key research and development projects, 2 provincial key research and development projects and technology transfer projects, and 3 municipal science and technology projects. All of them have completed the corresponding performance tasks and been successfully concluded.
• Researcher, Director of Shaanxi Provincial Engineering Research Center for Nano-Biomedical Detection, Director of Xi 'an Municipal Engineering Research Center for Clinical In Vitro Diagnostic Reagents.
• Chief Expert of the National Key Research and Development Program, Leading Talent of Middle-aged and Young Scientific and technological Innovation in Shaanxi Province, Young Science and Technology Star of Shaanxi Province, "National Leading Talent" of Xi 'an City, "Top Talent" of Xi 'an High-tech Zone.
• He has presided over and completed 5 national-level projects including the National Key Research and Development Program, 4 provincial and ministerial-level projects, obtained over 10 authorized invention patents, led the formulation of 1 group standard, and participated in the compilation of the book "Medical Magnetic Nanomaterials" (Science Press).
• Received the First and Second Prizes of the Shaanxi Provincial Science and Technology Progress Award, the title of "Advanced Collective in the National Science and Technology System's Fight Against COVID-19" (collective leader) from the Ministry of Science and Technology, the Invention and Innovation Award of the China Association for Invention, the Shaanxi Youth May 4th Medal, the title of "Most Beautiful Science and Technology Worker in Shaanxi", the Shaanxi Youth Science and Technology Award, and the First Prize of the 2024 China Medical Device Innovation and Entrepreneurship Competition, etc.
• He is currently a member of the China Association for Science and Technology of Young People, a member of the Medical Laboratory Engineering Branch of the Chinese Society of Biomedical Engineering, a member of the Laboratory and Clinical Branch of the Chinese Society of Cardiothoracic and Vascular Anesthesiology, and the deputy secretary-general of the Laboratory Medicine Specialized Committee of the Shaanxi Society of Integrated Traditional Chinese and Western Medicine, etc.
• Professor of the Second Grade at the School of Life Sciences and Medicine, Northwest University (appointed in 2010) and Doctoral Supervisor.
• Deputy Director of the National Engineering Research Center for Micro-Detection System and Director of the Shaanxi Engineering Research Center for Nano-Biomedical Detection.
• Director of the "Four Subjects and One Union" in Vitro Diagnostic Innovation University-Enterprise Joint Research Center of Shaanxi Province.
• The leader of the "Key Innovation Team for Nano-Biomedical Detection in Shaanxi Province".
• He has presided over and completed more than 10 projects, including those funded by the National Natural Science Foundation of China, the National "863" Program, the National Major Science and Technology Achievement Transformation Project, the National Major New Drug Creation Project, and the National Major Infectious Disease Prevention and Control Project.
• More than 100 papers have been published, and one first prize and two second prizes of the Shaanxi Science and Technology Award have been won.
• Received the Second Prize for Invention and Innovation from the China Association for Invention, the Individual Award for Innovation in Industry-University-Research Cooperation from China, and the "Best Innovation Award" from the International Federation of Inventors' Associations, among others.
• Professor Cui Yali serves as a member of the National Committee of the Chinese People's Political Consultative Conference, vice chairperson of the Shaanxi Provincial Committee of the China Democratic League, and a member of the Chinese Association of Rehabilitation Medicine for Health and Wellness.
• Member of the Working Committee, Standing Committee Member of the Cerebrovascular Disease Branch of the Chinese Geriatrics Society, and Drug Gene of the Chinese Pharmacological Society.
• Social positions such as Standing Committee Member of the Organization Committee, Chairperson of the Community Health Promotion Committee of the Shaanxi Health Care Society, Supervisor of the Shaanxi Women Science and Technology Workers Association, and Vice President of the Shaanxi Women Entrepreneurs Association. She has been honored with titles such as "Expert with Outstanding Contributions in Shaanxi Province", "Top Ten Women of Sanqin", "National March 8th Red Flag Bearer", and "Leading Talent in Innovation and Entrepreneurship of Gusu District, Suzhou".